Literature DB >> 6424782

Glycaemic control in diabetic nephropathy.

J J Bending, J C Pickup, G C Viberti, H Keen.   

Abstract

To investigate the quality of glycaemic control that is achievable in diabetic patients with persistent proteinuria and asymptomatic but declining renal function three matched groups of patients were studied. The first comprised diabetics with proteinuria receiving continuous subcutaneous insulin infusion; the second, diabetics without proteinuria receiving continuous subcutaneous insulin infusion; and the third, diabetics with proteinuria receiving conventional insulin treatment. Glycaemic control in patients receiving continuous subcutaneous insulin infusion was shown to be appreciably worse during the daytime in diabetics with proteinuria than in diabetics without proteinuria, although greatly superior to that in diabetics with proteinuria receiving conventional insulin treatment. The loss of glycaemic control in patients with proteinuria receiving continuous subcutaneous insulin infusion probably occurred as a response to daytime hypoglycaemia and a consequent reduction in the proportion of the total insulin dose given prandially. Difficulty in controlling blood glucose concentrations may be a factor in the failure of intensified insulin regimens to influence the progression of diabetic renal disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424782      PMCID: PMC1441321          DOI: 10.1136/bmj.288.6425.1187

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  27 in total

1.  Correlation between insulin requirement and renal retention in diabetic nephropathy.

Authors:  J L KALLIOMAKI; T K MARKKANEN; L B SOURANDER
Journal:  Acta Med Scand       Date:  1960-05-05

2.  Effect of Kimmelstiel-Wilson syndrome on insulin requirements in diabetes.

Authors:  J W RUNYAN; D HURWITZ; S L ROBBINS
Journal:  N Engl J Med       Date:  1955-03-10       Impact factor: 91.245

3.  CARBOHYDRATE METABOLISM IN NEPHRITIS.

Authors:  G C Linder; A Hiller; D D Van Slyke
Journal:  J Clin Invest       Date:  1925-02       Impact factor: 14.808

4.  Abnormalities in circulating beta cell peptides in chronic renal failure: comparison of C-peptide, proinsulin and insulin.

Authors:  J B Jaspan; M E Mako; H Kuzuya; P M Blix; D L Horwitz; A H Rubenstein
Journal:  J Clin Endocrinol Metab       Date:  1977-09       Impact factor: 5.958

5.  Carbohydrate metabolism in renal disease.

Authors:  I M Spitz; A H Rubenstein; I Bersohn; C Abrahams; C Lowy
Journal:  Q J Med       Date:  1970-04

6.  Glucose metabolism and insulin secretion in uremic, prediabetic, and normal subjects.

Authors:  E G Lowrie; J S Soeldner; C L Hampers; J P Merrill
Journal:  J Lab Clin Med       Date:  1970-10

7.  Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus.

Authors:  J C Pickup; H Keen; G C Viberti; M C White; E M Kohner; J A Parsons; K G Alberti
Journal:  Diabetes Care       Date:  1980 Mar-Apr       Impact factor: 19.112

8.  Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.

Authors:  R S Sherwin; C Bastl; F O Finkelstein; M Fisher; H Black; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

9.  Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.

Authors:  G C Viberti; J C Pickup; R J Jarrett; H Keen
Journal:  N Engl J Med       Date:  1979-03-22       Impact factor: 91.245

10.  Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes.

Authors:  G C Viberti; R W Bilous; D Mackintosh; J J Bending; H Keen
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.